Drug recalls (page 7)

748 recalls.

• Children's Healthcare of Atlanta recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Dynarex recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Dynarex recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Green Guard Antiseptic Wipes recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Hand Sanitizing Wipes recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• WP WipesPlus Hand Sanitizing Wipes recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Med-Nap Cleansing Towelettes recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Cleansing Towelette recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Dynarex Obstetrical Towelettes Cleanser recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Wipes Plus recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• BZK Antiseptic Towelettes recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Med Nap BZK Antiseptic Towelettes recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Medi-First Antiseptic Wipes recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Savannah Antibacterial Towelettes recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Max Packaging Antibacterial Towelette recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• 1) BZK Antiseptic Towelettes recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• First Aid Only BZK Antiseptic Towelette recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Dukal BZK Antiseptic Towelette recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• First Aid Only BZK Antiseptic Towelettes recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• First Aid Only BZK Antiseptic Towelettes recall (ACME UNITED CORPORATION)
  DrugClass IIReported March 11, 2026 · CGMP Deviations
• Metoprolol Succinate Extended-Release Tablets recall (Teva Pharmaceuticals USA, Inc)
  DrugClass IIReported March 11, 2026 · Failed Dissolution Specifications
• Metoprolol Succinate Extended-Release Tablets recall (Teva Pharmaceuticals USA, Inc)
  DrugClass IIReported March 11, 2026 · Failed Dissolution Specifications
• Metoprolol Succinate Extended-Release Tablets recall (Teva Pharmaceuticals USA, Inc)
  DrugClass IIReported March 11, 2026 · Failed Dissolution Specifications
• Metoprolol Succinate Extended-Release Tablets recall (Teva Pharmaceuticals USA, Inc)
  DrugClass IIReported March 11, 2026 · Failed Dissolution Specifications
• BioGlo Fluorescein Sodium Ophthalmic Strips USP recall (Wizcure Pharmaa Private Limited)
  DrugClass IIReported March 4, 2026 · Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
• Bio Glo Fluorescein Sodium Ophthalmic Strips USP recall (Wizcure Pharmaa Private Limited)
  DrugClass IIReported March 4, 2026 · Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
• CHNaO Fluorescein Sodium Ophthalmic Strips recall (Wizcure Pharmaa Private Limited)
  DrugClass IIReported March 4, 2026 · Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
• Vista Gonio Eye Lubricant recall (Wizcure Pharmaa Private Limited)
  DrugClass IIReported March 4, 2026 · Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
• Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief... recall (Wizcure Pharmaa Private Limited)
  DrugClass IIReported March 4, 2026 · Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
• Vista Gel Hypromellose USP 0.3% w/v recall (Wizcure Pharmaa Private Limited)
  DrugClass IIReported March 4, 2026 · Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
• Vista Tears Polyethylene Glycol 400 0.4% w/v recall (Wizcure Pharmaa Private Limited)
  DrugClass IIReported March 4, 2026 · Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
• Eptifibatide Injection recall (Slate Run Pharmaceuticals)
  DrugClass IIIReported March 4, 2026 · Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved...
• Amantadine HCl recall (AvKARE)
  DrugClass IIReported March 4, 2026 · Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
• Adbry recall (LEO PHARMA INC)
  DrugClass IIReported March 4, 2026 · Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.
• UDENYCA recall (McKesson)
  DrugClass IReported February 18, 2026 · Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the...
• Cetrorelix Acetate for Injection recall (Meitheal Pharmaceuticals, Inc)
  DrugClass IIReported February 18, 2026 · Defective Delivery System: Missing or duplicated needles within the injection kit
• Oxycodone Hydrochloride Tablets recall (Amerisource Health Services LLC)
  DrugClass IIReported February 18, 2026 · Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.
• vancomycin HCl recall (Fresenius Kabi Compounding, LLC)
  DrugClass IIReported February 18, 2026 · Lack of Assurance of Sterility
• vancomycin HCl recall (Fresenius Kabi Compounding, LLC)
  DrugClass IIReported February 18, 2026 · Lack of Assurance of Sterility
• thiamine HCl recall (Fresenius Kabi Compounding, LLC)
  DrugClass IIReported February 18, 2026 · Lack of Assurance of Sterility
• ketamine HCl recall (Fresenius Kabi Compounding, LLC)
  DrugClass IIReported February 18, 2026 · Lack of Assurance of Sterility
• acyclovir sodium recall (Fresenius Kabi Compounding, LLC)
  DrugClass IIReported February 18, 2026 · Lack of Assurance of Sterility
• Testosterone 100mg Anastrozole 4mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone 87.5mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone 200mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone 100mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone 75mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone 100mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
  DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter
• Doxazosin Tablets recall (Unichem Pharmaceuticals USA Inc.)
  DrugClass IIIReported February 18, 2026 · Tablets/Capsules Imprinted with Wrong ID
• Pro Numb Tattoo Numbing Spray recall (Pro Numb Tattoo Numbing Spray LLC)
  DrugClass IIReported February 18, 2026 · cGMP deviations
• Pro Numb Tattoo Numbing Spray recall (Pro Numb Tattoo Numbing Spray LLC)
  DrugClass IIReported February 18, 2026 · cGMP deviations
• Diclofenac Sodium recall (SUN PHARMACEUTICAL INDUSTRIES INC)
  DrugClass IIReported February 11, 2026 · Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
• Rheumacare capsules recall (HANDELNINE GLOBAL LLC)
  DrugClass IReported February 11, 2026 · CGMP Deviations: product found to contain lead.
• Trazodone Hydrochloride recall (Granules Pharmaceuticals Inc.)
  DrugClass IIReported February 11, 2026 · Presence of Foreign Tablets/Capsules
• Bisoprolol Fumarate and Hydrochlorothiazide tablets recall (Unichem Pharmaceuticals USA Inc.)
  DrugClass IIReported February 11, 2026 · cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
• Glycopyrrolate Oral Solution recall (NOVADOZ PHARMACEUTICALS LLC)
  DrugClass IIIReported February 4, 2026 · Failed Impurities/Degradation Specifications
• methylprednisolone tablets recall (Greenstone Llc)
  DrugClass IIReported February 4, 2026 · Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information...
• INON ACE Antacid tablets recall (Sato Pharmaceutical Co., Ltd)
  DrugClass IIReported February 4, 2026 · Failed Disintegration Specifications: above the time expected.
• parodontax recall (Haleon US Holdings LLC)
  DrugClass IIIReported February 4, 2026 · Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles.
• Sterile Water for Irrigation recall (Baxter Healthcare Corporation)
  DrugClass IIReported February 4, 2026 · Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution
• Icosapent Ethyl capsules recall (Zydus Pharmaceuticals (USA) Inc)
  DrugClass IIReported January 28, 2026 · Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
• Thyroid recall (Specialty Process Labs LLC)
  DrugClass IIReported January 28, 2026 · Subpotent Drug
• Furosemide Tablets recall (Graviti Pharmaceuticals Private Limited)
  DrugClass IIReported January 28, 2026 · Presence of Foreign Substance
• Diclofenac Sodium Topical Gel recall (Cipla USA, Inc.)
  DrugClass IIIReported January 28, 2026 · Failed PH Specifications
• Lanreotide Injection recall (Cipla USA, Inc.)
  DrugClass IIReported January 21, 2026 · Presence of Particulate Matter.
• Toothpaste: a) COLGATE recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• Deodorant: a) Axe recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• Petroleum jelly: a) Vaseline Petroleum Jelly recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• LUCKY ICE recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• Personal Care recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• Carmex a) jar recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• Personal Care recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• Swan recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• TUMS a) Assorted recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• Halls Cough Drops a) BAGS recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• TYLENOL a) 500 MG. recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• PEPCID COMPLETE - 25CT recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• PEPTO BISMOL 32CT recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• CHILDREN NYQUIL recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• NYQUIL COLD & FLU -32CT/2PK recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
• LIQUID NYQUIL a) regular recall (GOLD STAR DISTRIBUTION INC)
  DrugClass IIReported January 21, 2026 · CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

← NewerOlder →